COSMOS Pharmaceutical Corporation (TYO:3349)

Market Cap	504.23B -28.9%
Revenue (ttm)	1.07T +6.7%
Net Income	31.38B +6.6%
EPS	395.96 +6.6%
Shares Out	79.26M
PE Ratio	16.07
Forward PE	15.37
Dividend	75.00 (1.15%)
Ex-Dividend Date	May 28, 2026

Volume	508,300
Open	6,441.00
Previous Close	6,515.00
Day's Range	6,314.00 - 6,442.00
52-Week Range	5,615.00 - 10,045.00
Beta	0.15
Analysts	Buy
Price Target	7,975.00 (+25.35%)
Earnings Date	Jul 13, 2026

About COSMOS Pharmaceutical

COSMOS Pharmaceutical Corporation engages in the retail sale of pharmaceuticals, cosmetics, daily necessities, and food products in Japan. The company offers general medicines, energy drinks, oral and nursing care products, vitamins, health foods, diet foods, and prescriptions; and hair care and bath products. It also provides baby products, detergents, insect repellents, air fresheners, bath and toilet products, cooking supplies, gardening supplies, household and cleaning supplies, and clothing; processed foods, daily necessities, seasonings, ...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1983
• Employees: 5,709
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 3349

Financial Performance

In fiscal year 2025, COSMOS Pharmaceutical's revenue was 1.01 trillion, an increase of 4.81% compared to the previous year's 964.99 billion. Earnings were 30.98 billion, an increase of 26.68%.

Analyst Summary

According to 10 analysts, the average rating for 3349 stock is "Buy." The 12-month stock price target is ¥7,975, which is an increase of 25.35% from the latest price.

Price Target

¥7,975

(25.35% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 10, 2026

Data Sources Report a data error